首页|手法复位对耳石症患者临床疗效及症状缓解时间的影响分析

手法复位对耳石症患者临床疗效及症状缓解时间的影响分析

扫码查看
目的 探讨手法复位对耳石症患者临床疗效及症状缓解时间的影响。方法 选择 70 例耳石症患者为研究对象,依据随机数字表法分为观察组及对照组,每组 35 例。对照组予以甲磺酸倍他司汀治疗,观察组在对照组基础上实施手法复位治疗。比较两组患者症状缓解时间、病情程度、复发情况、不良反应发生情况、生活质量评分。结果 观察组眩晕缓解时间(4。26±0。71)d以及眼球震颤缓解时间(3。81±0。67)d均短于对照组的(7。65±1。42)、(6。93±1。20)d(P<0。05)。治疗后,两组眩晕障碍量表(DHI)评分与前庭症状指数(VSI)评分均较治疗前降低,且观察组DHI评分(64。22±1。16)分与 VSI评分(29。65±1。32)分均低于对照组的(70。29±2。88)、(40。33±2。72)分(P<0。05)。观察组复发率为 5。71%,低于对照组的 22。86%(P<0。05)。观察组不良反应发生率为 2。86%,低于对照组的 22。86%(P<0。05)。观察组社会功能、生理功能、情感职能、生理职能、精神健康、活力、总体健康、躯体疼痛评分分别为(85。67±1。58)、(85。67±1。82)、(86。48±2。33)、(87。18±1。83)、(87。46±1。82)、(86。25±2。14)、(86。95±2。16)、(86。73±2。05)分,均高于对照组的(81。35±2。15)、(82。67±2。26)、(82。72±2。81)、(83。15±2。37)、(83。27±2。36)、(84。56±2。28)、(82。88±2。34)、(82。43±2。66)分(P<0。05)。结论 手法复位能改善耳石症患者的病情,加速不良症状缓解,提升患者生活质量,值得推广应用。
Analysis of the effect of manual reduction on clinical efficacy and symptom relief time in patients with otolithiasis
Objective To explore the effect of manual reduction on clinical efficacy and symptom relief time in patients with otolithiasis.Methods 70 patients with otolithiasis were selected as the study subjects.They were randomly divided into an observation group and a control group by random numerical table,each with 35 cases.The control group was treated with betahistine mesylate,while the observation group was combined with manual reduction based on the control group.The symptom relief time,severity of illness,recurrence,adverse reactions,and quality of life were compared between the two groups of patients.Results The duration of relief for dizziness and nystagmus in the observation group were(4.26±0.71)and(3.81±0.67)d,which were shorter than(7.65±1.42)and(6.93±1.20)d in the control group(P<0.05).The dizziness handicap inventory(DHI)score and vestibular symptom index(VSI)score of the two groups decreased compared to those before treatment;the observation group had DHI score of(64.22±1.16)points and VSI score of(29.65±1.32)points,which were lower than(70.29±2.88)and(40.33±2.72)points in the control group(P<0.05).The recurrence rate of the observation group was 5.71%,which was lower than 22.86%of the control group(P<0.05).The incidence of adverse reactions in the observation group was 2.86%,which was lower than 22.86%in the control group(P<0.05).The scores of social function,physical function,role-emotional,role-physical,mental health,vitality,general health and bodily pain in the observation group were(85.67±1.58),(85.67±1.82),(86.48±2.33),(87.18±1.83),(87.46±1.82),(86.25±2.14),(86.95±2.16)and(86.73±2.05)points,which were higher than(81.35±2.15),(82.67±2.26),(82.72±2.81),(83.15±2.37),(83.27±2.36),(84.56±2.28),(82.88±2.34)and(82.43±2.66)points in the control group(P<0.05).Conclusion Manual reduction can improve the condition of patients with otolithiasis,accelerate the relief of adverse symptoms,and improve the quality of life of patients,which is worth promoting and applying.

Manual reductionOtolithiasisBetahistine mesylateDizzinessNystagmus

谢壬海、陈李城

展开 >

353400 南平市浦城县医院

手法复位 耳石症 甲磺酸倍他司汀 眩晕 眼球震颤

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(15)